FDA gives Saniona candidate priority status
![Photo: Andrew Kelly/REUTERS / X02844](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13154909.ece/ALTERNATES/schema-16_9/doc7gtk63oxtd2t9c7kk2q.jpg)
The US Food and Drug Administration FDA has given orphan drug priority status to Saniona's drug candidate Tesomet for treating hypothalamic obesity (HO), according to a press release on Monday.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Saniona borrows USD 10m for clinical studies
For subscribers